Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (441-450 of 651) with videos related to

Pageof 66
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2016
An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in SchizophreniaDarrick T Balu, Yan Li, Shunsuke Takagi, et al.
JAMA|July 12, 2022
Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019Noel Eldridge, Yun Wang, Mark Metersky, et al.
ACS Chemical Neuroscience|December 22, 2012
Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding modeGregory J Digby, Thomas J Utley, Atin Lamsal, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptorR A Porter, W N Chan, S Coulton, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2003
Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatmentMichael J Marino, David L Williams, Julie A O'Brien, et al.
Journal of Gastroenterology and Hepatology|November 22, 2015
Additive impact of pre-liver transplant metabolic factors on survival post-liver transplantLeon A Adams, Oscar Arauz, Peter W Angus, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2021
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M<sub>1</sub>Paul K Spearing, Hyekyung P Cho, Vincent B Luscombe, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesisDarrell H G Crawford, Linda M Fletcher, Stefan G Hubscher, et al.
Molecular Pharmacology|March 17, 2018
Differential Pharmacology and Binding of mGlu<sub>2</sub> Receptor Allosteric ModulatorsDaniel E O'Brien, Douglas M Shaw, Hyekyung P Cho, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primatesRobert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
Pageof 66

Showing results (441-450 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2016
An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in SchizophreniaDarrick T Balu, Yan Li, Shunsuke Takagi, et al.
JAMA|July 12, 2022
Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019Noel Eldridge, Yun Wang, Mark Metersky, et al.
ACS Chemical Neuroscience|December 22, 2012
Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding modeGregory J Digby, Thomas J Utley, Atin Lamsal, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptorR A Porter, W N Chan, S Coulton, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2003
Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatmentMichael J Marino, David L Williams, Julie A O'Brien, et al.
Journal of Gastroenterology and Hepatology|November 22, 2015
Additive impact of pre-liver transplant metabolic factors on survival post-liver transplantLeon A Adams, Oscar Arauz, Peter W Angus, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2021
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M<sub>1</sub>Paul K Spearing, Hyekyung P Cho, Vincent B Luscombe, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesisDarrell H G Crawford, Linda M Fletcher, Stefan G Hubscher, et al.
Molecular Pharmacology|March 17, 2018
Differential Pharmacology and Binding of mGlu<sub>2</sub> Receptor Allosteric ModulatorsDaniel E O'Brien, Douglas M Shaw, Hyekyung P Cho, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primatesRobert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
Pageof 66